ABSTRACT
Given the world’s population is aging (United Nations, 2009), cognitive decline, ranging from mild age-related change to severe dementia, is a major public health concern. In the absence of a cure, effective disease modification has become the therapeutic goal. Modifiable risk factors for cognitive decline have been identified that could be targeted in order to slow the onset or progression of age-related cognitive decline.
